The Relationship between Zinc, Copper and Manganese Levels on Bone Formation, Which Increases the Risk of Uterine Cancer

Abstract

Due to the lack of previous studies on the impact of osteoporosis on the incidence of uterine cancer, and the rapid spread of uterine cancer in recent years all the world, and the exact mechanism of its occurrence is not entirely clear. The study focused on the possibility of consideration of osteoporosis as a marker to uterine cancer by study the relationship between osteoporosis and uterine cancer through the measurement of both Zinc, Copper and Manganese which operate inside the body as antioxidation when its linked with enzymes, which affect the bone density and their impact on the incidence of uterine cancer. The study involved collecting samples from hospitals in Mosul, women without uterine cancer as the control group and divided into two groups (44 women with good health and 38 women diagnosed as osteoporosis only). And patients women also divided to the two groups did not receive any treatment (43 with uterine cancer only and 58 women with osteoporosis and uterine cancer). Each patient was evaluated clinically and then was estimated Zinc, Copper and Manganese in serum using atomic absorption spectroscopy technique as well as appreciation of both estrogen and progesterone in the serum. The results showed that osteoporosis may increase the incidence of uterine cancer through hormonal changes and the concentration of antioxidants and their impact on the bone-building and thus its impact on the amount of free radicals in the body which cause increase the likelihood of uterine cancer before and after menopause. The study showed that osteoporosis is a new risk factors increase the likelihood of uterine cancer. Women should pay attention to bone health by maintaining the concentration of antioxidant mineral, which has a role in bone health and prevent fragility and early diagnosis and treatment of osteoporosis to reduce the risk of uterine cancer.

Keywords

• Uterine cancer
• Zinc
• Copper
• Osteoporosis

References

1. Yang, S., Thiel, K. W. and Leslie, K. K., Trends in Endocrinology & Metabolism Progesterone 22(4): 145-152, (2011). Haughian, J. M., Reno, E. M., Thorne, A. M., and Bradford, A. P., Int J Cancer.125(11): 2556-2564, (2009). Colombo, N., Preti, E., Landoni, F., Carinelli, S., Colombo, A., Marini, C. and Sessa, C., Ann Oncol. 22(6): 35-39, (2011). Haughian, J. M., Jackson, T. A., Koterwas, D. M. and Bradford, A. P., Endocrine-Related Cancer. 13: 1251-1267, (2006). Demirci, S., Ozsaran, Z., Celik, H. A., Aras, A. B. and Aydin, H. H., Tumori. 97: 290-295, (2011). Badjatia, N., Satyam, A., Singh, P., Seth, A. and Sharma, A., Urol Oncol. 28: 360-367, (2010). Gokul, S., Patil, V. S., Jailkhani, R., Hallikeri, K. and Kattappagari, K.K., Oral Dis. 16: 29-33, (2010). Sugiura , M., Nakamura, M., Ogawa, K., Ikoma, Y., Ando, F., Shimokata , H., and Yano, M., International Osteoporosis Foundation and National Osteoporosis Foundation. 22: 143-152, (2010). Sendur, O. S., Turan, Y., Tastaban, E. and Serter, M., Joint bone spine. 76(5): 514 – 518, (2009). Chuin, A., Labonté, M., Tessier, D., Khalil, A., Bobeuf, F., Doyon, C. Y., Rieth, N. and Dionne, I. J., International Osteoporosis Foundation and National Osteoporosis Foundation. 20(7): 1253-1258, (2009). Sahni, S., Hannan, M. T., Gagnon, D., Blumberg, J., Cupples, L.A ., Kiel, D.P., and Tucker, K.L., International Osteoporosis Foundation and National Osteoporosis Foundation. 20(11): 1853-1861, (2009). Richmond, S. J., Brown, S. R., Campion, P. D., Porter, A. J., Moffett, J. A., Jackson, D. A., Featherstone, V. A. and Taylor, A. J., Complement Ther Med. 17(5-6): 249-256, (2009). Kazi, T. G., Afridi, H. I., Kazi, N., Jamali, M. K., Biol Trace Elem Res. 122(1): 1-18, (2008). Antanasopoulos N., Flame methods manual for atomic absorption, published by GBC scientific equipment PTY Ltd, 2010. Kirkpatrick L. Feeney B. C. A Simple Guide to IBM SPSS Statistics for Version 18.0 and 19.0 11th Edn., Wadsworth Cengage Learning, Belmont, ISBN-10:1111352550,2012; P115. Kim, H. J., Kim, T. J. and Lee, Y. Y., J Gynecol Oncol. 24(2): 120-127, (2013). Llaurado, M., Ruiz, A., Majem, B., Ertekin, T., Colas, E., Pedrola, N. and Reventos, J., Molecular and cellular endocrinology. 358(2): 244-255, (2012). Lee, W. L., Lee, F. K., Su, W. H., Tsui, K. H., Kuo, C. D., Hsieh, S. L. and Wang, P. H., Taiwanese journal of obstetrics & gynecology. 51(4): 495-505, (2012). McTiernan, A., Irwin, M. and Vongruenigen, V., Journal of clinical oncology. 28(26): 4074-4080, (2010). Wehrli, F. W., J Bone Miner Res. 23(5): 730-740, (2008). Raisz, L. G., Pathogenesis of osteoporosis: concepts, conflicts and prospects. J Clin Invest. 115: 3318-3325, (2005). Orenzo, J., Horowitz, M. and Choi, Y., Endocrine Reviews. 29(4): 403-440, (2008). Mackinnon, E. S., Rao, A. V. and Rao, L. G., The Journal of Nutrition, Health & Aging.15(2): 133-138, (2011). Baek, K. H., Oh, K. W., Lee, W. Y., Lee, S. S., Kim, M. K. and Kwon, H. S., Calcified Tissue International. 87(3): 226-235, (2010). Zhang, J., Munger, R.G., West, N. A., Cutler, D. R, Am. J. Epidemiol. 163 (1): 9-17, (2006). Medeiros Pinheiro, M., Ciconelli, R. M., Chaves, G. V., Aquino, L., Juzwiak, C. R., Genaro, P. D. S. and Ferraz, M. B., Nutrition Journal. 10(39): 1-8, (2011). Berger, M.M., Clin Nutr. 24: 172-83, (2005). Clark, S. F., Nutr Clin Pract. 17: 5-17, (2002). Oveisi, M. R., Sadeghi, N,. Jannat, B., Hajimahmoodi, M., Hadjibabaie, M. and Behfar, A., Iranian Journal of Basic Medical Sciences. 14(2): 158-166, (2011). Chavan, S. N., More, U., Mulgund, S., Saxena, V. and Sontakke, A. N., Indian Journal of Clinical Biochemistry. 22 (2): 101-105, (2007).